BRAF and cancer: The activation mutation of serine threonine kinase v-RAF mouse sarcoma virus oncogene B1 (BRAF) is an important biomarker in human benign and malignant tumors, and most mutations affect BRAFV600 in exon 15 of BRAF gene (65).